Literature DB >> 33070968

Transplantation of microencapsulated neural stem cells inhibits neuropathic pain mediated by P2X7 receptor overexpression.

Wen-Jun Zhang1, Jin-Feng Zhu1, Zheng-Ming Zhu2.   

Abstract

BACKGROUND: Neuropathic pain (NPP) is a common clinical symptom, its pathological mechanism is complex, and there is currently no good treatment method. Therefore, exploring the treatment method of NPP is a critical issue that needs to be urgently solved.
METHODS: Neural stem cells (NSC) and microencapsulated neural stem cells (MC-NSC) were transplanted into the site of sciatic nerve injury, and behavioral methods were used to detect changes in pain. Expression levels of P2X7R were detected in the dorsal root ganglion (DRG) by molecular biological methods.
RESULTS: After sciatic nerve injury, mechanical withdrawal thresholds (MWT) and thermal withdrawal latency (TWL) of rats were significantly reduced, the expression levels of P2X7R in the DRG were significantly increased. After transplantation of NSC and MC-NSC, it was found that expression levels of P2X7R were significantly reduced and pain was significantly suppressed. Importantly, compared with NSC transplantation, MC-NSC could better reduce the expression levels of P2X7R and inhibit pain.
CONCLUSION: MC-NSC can better decrease the expression levels of P2X7R and relieve NPP. Our results provide a novel method and data support for the treatment of NPP.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Microencapsulated (MC); Neural stem cells (NSC); Neuropathic pain (NPP); P2X7 receptor (P2X7R)

Year:  2020        PMID: 33070968     DOI: 10.1016/j.bbrc.2020.09.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Involvement of P2X7 receptors in chronic pain disorders.

Authors:  Wen-Jing Ren; Peter Illes
Journal:  Purinergic Signal       Date:  2021-11-20       Impact factor: 3.765

2.  Cross-Sectional Survey of Clinical Trials of Stem Cell Therapy for Heart Disease Registered at ClinicalTrials.gov.

Authors:  Rong Yang; Yonggang Zhang; Xiaoyang Liao; Ru Guo; Yi Yao; Chuanying Huang; Li Qi
Journal:  Front Cardiovasc Med       Date:  2021-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.